| 1 | [SID103189265] | Active | IC50 | 0.001 | Antihistaminic activity against Histamine H1 receptor was measured on isolated terminal part of guinea pig ileum [AID86581, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.001 [uM] | | BioAssay | Antihistaminic activity against Histamine H1 receptor was measured on isolated terminal part of guinea pig ileum | | AID | 86581 | | BioAssay type | Literature | | Target | | | PubMed | 1977909 | | Data Table |  |
|
| 2 | [SID103189265] | Active | Kd | 0.01175 | Antagonist activity at H1R in guinea pig ileum assessed as inhibition of histamine-induced muscle contraction after 15 mins [AID626461, Type: Literature] | Histamine H1 receptor [gi:399889] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | Kd | 0.01175 [uM] | | BioAssay | Antagonist activity at H1R in guinea pig ileum assessed as inhibition of histamine-induced muscle contraction after 15 mins | | AID | 626461 | | BioAssay type | Literature | | Target | Histamine H1 receptor [gi:399889] | | PubMed | 21944853 | | Data Table |  |
|
| 3 | [SID103189265] | Active | Ki | 0.01479 | Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting [AID626411, Type: Literature] | Histamine H1 receptor [gi:547645] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | Ki | 0.01479 [uM] | | BioAssay | Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting | | AID | 626411 | | BioAssay type | Literature | | Target | Histamine H1 receptor [gi:547645] | | PubMed | 21944853 | | Data Table |  |
|
| 4 | [SID103189265] | Active | Ki | 0.01479 | Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting [AID626411, Type: Literature] | Histamine H1 receptor [gi:547645] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | Ki | 0.01479 [uM] | | BioAssay | Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting | | AID | 626411 | | BioAssay type | Literature | | Target | Histamine H1 receptor [gi:547645] | | PubMed | 21944853 | | Data Table |  |
|
| 5 | [SID103189265] | Active | IC50 | 0.162 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.162 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 6 | [SID103189265] | Active | IC50 | 0.162 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.162 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 7 | [SID103189265] | Active | IC50 | 0.162 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.162 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 8 | [SID103189265] | Active | IC50 | 0.162 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.162 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 9 | [SID103189265] | Active | IC50 | 0.171 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.171 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 10 | [SID103189265] | Active | IC50 | 0.171 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.171 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 11 | [SID11111059] | Active | Potency | 0.1995 | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response [AID943, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 11111059 | | CID | 3100 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response | | AID | 943 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 12 | [SID11111059] | Active | Potency | 0.1995 | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response [AID943, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 11111059 | | CID | 3100 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response | | AID | 943 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 13 | [SID11111059] | Active | Potency | 0.1995 | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response [AID943, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 11111059 | | CID | 3100 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response | | AID | 943 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 14 | [SID103189265] | Active | IC50 | 0.346 | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625151, Type: other] | Muscarinic acetylcholine receptor M [gi:113118] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.346 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625151 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113118] | | PubMed | | | Data Table |  |
|
| 15 | [SID103189265] | Active | IC50 | 0.346 | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625151, Type: other] | Muscarinic acetylcholine receptor M [gi:113118] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.346 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625151 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113118] | | PubMed | | | Data Table |  |
|
| 16 | [SID103189265] | Active | IC50 | 0.372 | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625154, Type: other] | Muscarinic acetylcholine receptor M [gi:23503039] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.372 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625154 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:23503039] | | PubMed | | | Data Table |  |
|
| 17 | [SID103189265] | Active | IC50 | 0.372 | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625154, Type: other] | Muscarinic acetylcholine receptor M [gi:23503039] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.372 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625154 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:23503039] | | PubMed | | | Data Table |  |
|
| 18 | [SID103189265] | Active | IC50 | 0.372 | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625154, Type: other] | Muscarinic acetylcholine receptor M [gi:23503039] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.372 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625154 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:23503039] | | PubMed | | | Data Table |  |
|
| 19 | [SID103189265] | Active | IC50 | 0.647 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.647 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 20 | [SID103189265] | Active | IC50 | 0.647 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.647 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 21 | [SID103189265] | Active | IC50 | 0.647 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.647 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 22 | [SID103189265] | Active | IC50 | 0.647 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.647 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 23 | [SID103189265] | Active | IC50 | 0.647 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.647 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 24 | [SID103189265] | Active | IC50 | 0.98 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.98 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 25 | [SID103189265] | Active | IC50 | 0.98 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.98 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 26 | [SID103189265] | Active | IC50 | 0.98 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 0.98 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 27 | [SID103189265] | Active | IC50 | 1.05 | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 28 | [SID103189265] | Active | IC50 | 1.05 | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 29 | [SID103189265] | Active | IC50 | 1.05 | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 30 | [SID103189265] | Active | IC50 | 1.05 | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 31 | [SID103189265] | Active | IC50 | 1.05 | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 32 | [SID103189265] | Active | IC50 | 1.05 | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 33 | [SID103189265] | Active | IC50 | 1.118 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.118 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 34 | [SID103189265] | Active | IC50 | 1.118 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.118 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 35 | [SID103189265] | Active | IC50 | 1.118 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.118 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 36 | [SID103189265] | Active | IC50 | 1.295 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.295 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 37 | [SID103189265] | Active | IC50 | 1.295 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.295 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 38 | [SID103189265] | Active | IC50 | 1.295 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 1.295 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 39 | [SID11111059] | Active | Potency | 2.5119 | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response [AID944, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 11111059 | | CID | 3100 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response | | AID | 944 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 40 | [SID11111059] | Active | Potency | 2.5119 | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response [AID944, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 11111059 | | CID | 3100 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response | | AID | 944 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 41 | [SID11111059] | Active | Potency | 2.5119 | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response [AID944, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 11111059 | | CID | 3100 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response | | AID | 944 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 42 | [SID103189265] | Active | IC50 | 2.5704 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 2.5704 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 43 | [SID103189265] | Active | IC50 | 2.5704 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 2.5704 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 44 | [SID103189265] | Active | IC50 | 2.5704 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 2.5704 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 45 | [SID103189265] | Active | IC50 | 2.5704 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 2.5704 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 46 | [SID103189265] | Active | IC50 | 2.5704 | Inhibition of human ERG [AID576612, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 2.5704 [uM] | | BioAssay | Inhibition of human ERG | | AID | 576612 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 21185626 | | Data Table |  |
|
| 47 | [SID103189265] | Active | IC50 | 3.542 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) [AID625207, Type: other] | Sodium-dependent noradrenaline transporter [gi:128616] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 3.542 [uM] | | BioAssay | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | | AID | 625207 | | BioAssay type | other | | Target | Sodium-dependent noradrenaline transporter [gi:128616] | | PubMed | | | Data Table |  |
|
| 48 | [SID103189265] | Active | IC50 | 3.542 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) [AID625207, Type: other] | Sodium-dependent noradrenaline transporter [gi:128616] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 3.542 [uM] | | BioAssay | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | | AID | 625207 | | BioAssay type | other | | Target | Sodium-dependent noradrenaline transporter [gi:128616] | | PubMed | | | Data Table |  |
|
| 49 | [SID11111060] | Active | Potency | 3.9811 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 [AID891, Type: confirmatory] | cytochrome P450 2D6 isoform 1 [Homo sapiens] [gi:40805836] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 11111060 | | CID | 3100 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 | | AID | 891 | | BioAssay type | confirmatory | | Target | cytochrome P450 2D6 isoform 1 [Homo sapiens] [gi:40805836] | | PubMed | | | Data Table |  |
|
| 50 | [SID103189265] | Active | IC50 | 6 | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex [AID205267, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103189265 | | CID | 3100 | | Outcome | Active | | IC50 | 6 [uM] | | BioAssay | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex | | AID | 205267 | | BioAssay type | Literature | | Target | | | PubMed | 2579237 | | Data Table |  |
|